Cargando…

Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030

BACKGROUND: Lack of Hepatitis C virus (HCV) incidence data in (Norwegian) high-risk groups impedes the ability to make informed decisions on prevention measures. Thus we rely on modelling to estimate the incidence and burden of HCV infections. METHODS: We constructed a compartmental model for HCV in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijerink, Hinta, White, Richard A, Løvlie, Astrid, de Blasio, Birgitte Freiesleben, Dalgard, Olav, Amundsen, Ellen J., Melum, Espen, Kløvstad, Hilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543437/ https://www.ncbi.nlm.nih.gov/pubmed/28774261 http://dx.doi.org/10.1186/s12879-017-2631-2

Ejemplares similares

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial
por: Kløvstad, Hilde, et al.
Publicado: (2013)

Re–evaluation of the cost–effectiveness and effects of childhood rotavirus vaccination in Norway
por: Hansen Edwards, Christina, et al.
Publicado: (2017)

Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2020)

Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants
por: Jalali, Neda, et al.
Publicado: (2022)

Correction to: Risk conditions in children hospitalized with influenza in Norway, 2017–2019
por: Hauge, Siri Helene, et al.
Publicado: (2021)

Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway – And the Influence of Vaccination Timing
por: Freiesleben de Blasio, Birgitte, et al.
Publicado: (2012)

Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Burden of medically attended influenza in Norway 2008‐2017
por: Hauge, Siri Helene, et al.
Publicado: (2019)

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

MRSA infections in Norway: A study of the temporal evolution, 2006-2015
por: Di Ruscio, Francesco, et al.
Publicado: (2017)

The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway
por: Andreassen, A. Elizabeth S., et al.
Publicado: (2017)

Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: A cross sectional study
por: Kløvstad, Hilde, et al.
Publicado: (2012)

Etiology of viral respiratory tract infections in hospitalized adults, and evidence of the high frequency of prehospitalization antibiotic treatment in Norway
por: Debes, Sara, et al.
Publicado: (2021)

Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models
por: Del Fava, Emanuele, et al.
Publicado: (2016)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Methicillin-Resistant Staphylococcus aureus (MRSA) Is Increasing in Norway: A Time Series Analysis of Reported MRSA and Methicillin-Sensitive S. aureus Cases, 1997–2010
por: Moxnes, John F., et al.
Publicado: (2013)

Analysis of multi-level spatial data reveals strong synchrony in seasonal influenza epidemics across Norway, Sweden, and Denmark
por: Morris, Sinead E., et al.
Publicado: (2018)

Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009
por: Rimšelienė, Gražina, et al.
Publicado: (2011)

The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster
por: Marangi, Luigi, et al.
Publicado: (2017)

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Effects of non-compulsory and mandatory COVID-19 interventions on travel distance and time away from home, Norway, 2021
por: Kamineni, Meghana, et al.
Publicado: (2023)

Clinical Outcome of Viral Respiratory Tract Infections in Hospitalized Adults in Norway: High Degree of Inflammation and Need of Emergency Care for Cases With Respiratory Syncytial Virus
por: Debes, Sara, et al.
Publicado: (2022)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
por: Whelan, Jane, et al.
Publicado: (2016)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020
por: Steens, Anneke, et al.
Publicado: (2020)

The correlation between socioeconomic factors and COVID-19 among immigrants in Norway: a register-based study
por: Kjøllesdal, Marte, et al.
Publicado: (2021)

High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway
por: Osnes, Magnus N., et al.
Publicado: (2020)

A compelling demonstration of why traditional statistical regression models cannot be used to identify risk factors from case data on infectious diseases: a simulation study
por: Engebretsen, Solveig, et al.
Publicado: (2022)

Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway
por: Whittaker, Robert, et al.
Publicado: (2020)

COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study
por: Indseth, Thor, et al.
Publicado: (2021)

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave
por: Xue, Yiting, et al.
Publicado: (2010)

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic
por: Xue, Yiting, et al.
Publicado: (2012)

Frailty effects in networks: comparison and identification of individual heterogeneity versus preferential attachment in evolving networks
por: de Blasio, Birgitte Freiesleben, et al.
Publicado: (2011)

The Role of Polymorphonuclear Leukocyte Counts from Urethra, Cervix, and Vaginal Wet Mount in Diagnosis of Nongonococcal Lower Genital Tract Infection
por: Randjelovic, Ivana, et al.
Publicado: (2018)

Influenza in workplaces: transmission, workers’ adherence to sick leave advice and European sick leave recommendations
por: Edwards, Christina Hansen, et al.
Publicado: (2016)

A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022
por: Whittaker, Robert, et al.
Publicado: (2023)

A theoretical single-parameter model for urbanisation to study infectious disease spread and interventions
por: Engebretsen, Solveig, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dcdqednqgurv4gumt8vu08eevs